Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiative
Authors:
- Jan HenkelJHJan Henkel
- Andreas LanerALAndreas Laner
- Melanie LocherMLMelanie Locher
- Tobias WohlfromTWTobias Wohlfrom
- Birgit NeitzelBNBirgit Neitzel
- Kerstin BeckerKBKerstin Becker
- Teresa NeuhannTNTeresa Neuhann
- Angela AbichtAAAngela Abicht
- Verena Steinke-LangeVSVerena Steinke-Lange
- Barbara KlinkBKBarbara Klink
- Birgit EichhornBEBirgit Eichhorn
- Winfried SchmidtWSWinfried Schmidt
Open Access
- 21 January 2025
- journal article
- Published by Elsevier in The Breast
- Vol. 80, 103887
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The landscape of reported VUS in multi-gene panel and genomic testing: Time for a changeGenetics in Medicine, 2023
- Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patientsEuropean Journal of Human Genetics, 2023
- Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer SyndromeJAMA Oncology, 2021
- Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysisGenetics in Medicine, 2020
- A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsGenetics in Medicine, 2019
- Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesBreast Cancer, 2019
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesThe American Journal of Human Genetics, 2019
- Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patientsBreast Cancer Research and Treatment, 2017
- A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene DiscoveryHuman Mutation, 2016
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)Human Mutation, 2011